Liljequist S, Garrett K M, Tabakoff B
Eur J Pharmacol. 1984 Aug 17;103(3-4):343-8. doi: 10.1016/0014-2999(84)90497-7.
Characteristics of [3H]flunitrazepam ([3H]FLU) binding to cortical and cerebellar membrane receptors were examined following chronic (six days) administration of phenobarbital (PB) to C57B1 mice. Following PB treatment, the number of [3H]FLU binding sites (Bmax) was significantly reduced in both cerebral cortex and in cerebellum. No change in the affinity (KD) of these binding sites was observed. Using 3-methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo [4,3-beta]pyridazine (CL-218,872), further analysis revealed a significant decrease in the number of high-affinity CL-218,872 binding sites in cerebellar tissue. In the forebrain areas, however, a significant decrease in the number of low-affinity binding sites was found. Finally, the enhancement of [3H]FLU binding, produced by in vitro addition of pentobarbital, was significantly less pronounced in the cerebellum of PB-treated animals.
对C57B1小鼠进行苯巴比妥(PB)慢性(6天)给药后,检测了[3H]氟硝西泮([3H]FLU)与皮质和小脑膜受体结合的特性。PB处理后,大脑皮质和小脑中[3H]FLU结合位点的数量(Bmax)均显著减少。未观察到这些结合位点亲和力(KD)的变化。使用3-甲基-6-[3-(三氟甲基)苯基]-1,2,4-三唑并[4,3-β]哒嗪(CL-218,872)进一步分析发现,小脑组织中高亲和力CL-218,872结合位点的数量显著减少。然而,在前脑区域,低亲和力结合位点的数量显著减少。最后,体外添加戊巴比妥产生的[3H]FLU结合增强在PB处理动物的小脑中明显不那么明显。